Single leukocyte filter (Pall BC1B) fails in multidose cold blood cardioplegia  by Roth, Matthias et al.
1116 Brief communications 
The Journat of Thoracic and 
Cardiovascular Surgery 
June 1997 
essential. In this case, needle biopsy was unsuccessful and 
an open thoracotomy was performed. An alternative 
approach used in many centers would have been a thora- 
coscopic excision, which might have resulted in a shorter 
hospitalization. 
The precise etiology of the cystic lesion in this case is 
unknown. We speculate that hemorrhage and introduc- 
tion of a small amount of air occurred on removal of the 
chest drain. The local collection of blood and air, com- 
bined with later organization of the blood clot, resulted in 
the formation of a cystic lesion. The reported incidence of 
hemorrhage occurring as a complication of the clinical use 
of heparin varies between 1% to 32%. 3,4 Spontaneous 
hemorrhage at a number of sites, including intrathoracic 
hemorrhage, has been reported, 5 and this was a likely 
contributory factor in this case. 
Although the cystic lesion proved to be benign in this 
case, the normal features that aid differentiation of a 
"pseudotumor" from an actual tumor were absent. There 
was no pleural effusion elsewhere, the lesion was cystic, 
and there were no other medical conditions predisposing 
toward pleural fluid collection, such as cardiac failure or 
pleurisy. In such cases when intravenous heparin has been 
used, particularly in the presence of chest drains a hepa- 
rin-associated intrathoracic pseudotumor should be con- 
sidered as part of the differential diagnosis. Nevertheless, 
a histologic diagnosis is essential to exclude malignancy, 
and an open thoracotomy or thoracoscopic resection is 
necessary if less invasive means are unsuccessful. 
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SINGLE LEUKOCYTE FILTER (PALL BCIB) FALLS IN MULTIDOSE COLD BLOOD CARDIOPLEGIA 
Matthias Roth, MD, Erwin P. Bauer, MD, Oliver Reuthebuch, MD, and Wolf Peter K16vekorn, MD, 
Bad Nauheim, Germany 
Leukocyte depletion and its effect on reperfusion i jury 
has been thoroughly investigated over the past several 
years. It has been shown to prevent myocardial edema, to 
decrease the incidence of ventricular arrhythmias, and to 
reduce free radical-mediated lung injury and cardiac 
reperfusion injury in animal models. Neutrophil granulo- 
cytes may cause myocardial stunning as a result of pro- 
duction of oxygen-derived free radicals, which may dam- 
age cell membranes, arcoplasmic reticulum, and different 
enzymes. Furthermore, granulocytes can plug capillaries 
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during ischemia; after their degranulation, cell mem- 
branes may be damaged by different cell enzymes. Several 
reports describe leukocyte depletion in human beings. 
However, most results are not conclusive, especially with 
regard to filter efficiency. 1-3 This study was undertaken to 
test the efficiency of the Pall BCIB leukocyte filter (Pall 
Biomedical Products Corp., East Hills, N.Y 0 during mul- 
tidose cold blood cardioplegia. 
In a future study we intend to apply leukocyte-depleted 
blood during blood cardioplegic perfusion and during the 
first 5 minutes of reperfusion in selected patients with 
reduced left ventricular function (ejection fraction < 
35%) using a double-blind study protocol. Before doing 
this study, we wanted to test the efficiency of the Pall 
BC1B leukocyte filter for blood cardioplegia in 16 pa- 
tients. 
Methods. Intermittent cold blood cardioplegic solution 
was used in all patients. Before aortic declamping the "hot 
shot" was infused during 4 minutes (250 ml • min-1). All 
patients received a combination of antegrade (50%) and 
retrograde (50%) cardioplegic infusion. A single or a 
double leukocyte filter BCIB for blood cardioplegia (Pall 
Biomedical) was placed in the cardioplegia line before 
blood was mixed with cardioplegic solution. 
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Tab le  I. Filtration rate (%) of  blood cells with 
single and double Pall BC IB  leukocyte filter for 
blood cardioplegia (n = 8) 
Time SF DF p Value 
Leukocytes (t*l) I 97.6 + 0.89 99.7 ,+ 0.16 0.04 
II 86.5 ± 2.12 99.2 + 0.35 0.002* 
III 69.6 -+ 3.34 98.6 ± 0.40 0.002* 
IV 55.7_+ 3.72 95.6 -+ 1.11 0.002* 
Neutrophi/s (/*1) I 97.6 _+ 1.09 99.9 ,+ 0.07 0.1 
II 86 _+ 2.98 99 +_ 0.91 0.002* 
III 72.6 ± 2.63 98 _+ 0.36 0.002* 
[V 53.3 _+ 4.30 95.2 _+ 0.70 0.002* 
Lymphocytes (p.1) I 97 ± 0.73 99.5 +_ 0.15 0.02 
II 88.8 ± 2.27 99.5 ± 0.13 0.002* 
III 53.4 _+ 4.82 99.8 _+ 0.12 0.002* 
IV 65.6 ± 5.00 93.3 _+ 0.75 0.002* 
PtateIets (103/t,1) I 7.1 +_ 1.78 13.9 _+ 1.15 0.02 
II 6.8_+ 0.88 18.1 + 1.79 0.002* 
III 2.7 _+ 0.48 5 ± 0.95 0.08 
IV 0.7 ± 0.42 5.5 -+ 1.05 0.002* 
Values for fiitration rate are given as mean plus or minus tandard error of 
the mean. n, Number of patients in each group; SF, single Pall BC1B 
leukocyte filter; DF, double Pall BCIB leukocyte filter; time I,, initial blood 
cardioplegia; time II, second blood cardioplegia; time III, third blood 
cardioplegia; time IV, terminal blood cardioplegia (hot shot). 
*p < 0.01, significant difference from single filter rate versus double filter 
rate. 
Blood samples for blood cell counts were collected 
proximal and distal to the leukocyte filter. Blood cell 
counts were immediately determined on samples contain- 
ing ethylenediaminetetraacetic ac d with the use of a 
counter (Sysmex K 1000, Sysmex Corporation of America, 
Long Grove, Ill.) and differential cell counting in Na- 
geotte chambers. 
The results are presented as the mean -+ standard error 
of the mean. Statistical analysis was performed by means 
of the Mann-Whitney U test for difference in medians, 
after an analysis of variance. A p value < 0.01 was 
considered to be statistically significant. 
Results. Filtration rates of blood cells are depicted in 
Table I. After the second period of cardioplegia, the 
filtration rate of leukocytes in patients with only one filter 
was significantly lower than that of patients with two 
filters. Similar results were obtained from neutrophil and 
lymphocyte counts. Platelets were barely filtered in either 
group. However, the filtration rate for platelets was higher 
in the double filter grou p . 
Discussion. Ishihara and coworkers 3 demonstrated 
that elimination of neutrophils by a filter down-regulated 
neutrophil elastase and lipid peroxidation, resulting in 
significantly lower values of creatine kinase MB. They 
summarized that leukocyte removal filters may decrease 
the myocardial damage caused by neutrophils during cold 
blood cardioplegia in cardiac operations. Sawa and asso- 
ciates ~ found that use of terminal leukocyte-depleted 
blood cardioplegia reduced the release of oxygen-derived 
free radicals and the amount of catecholamine support. 
However, Mihaljevic and colleagues 2 could not demon- 
strate a favorable ffect after use of a leukocyte filter. 
Heggie and coworkers 4 reported a leukocyte filtration 
rate of 75% for up to 5.3 liters of whole blood when a Pall 
BC1B filter was used; the filtration rates for platelets and 
erythrocytes were 15% and 2.5%, respectively. In our 
study, the leukocyte filtration rates when a single Pall 
BC1B filter was used were 97.6% and 86.5% during the 
first two cardioplegic perfusions. However, during the 
following perfusions, the filtration rate in the single filter 
group was significantly lower than in the double filter 
group. Thus we could demonstrate that the filtration rate 
of one single filter is insufficient after just two perfusions 
of cardioplegic solution. Inasmuch as leukocyte depletion 
increases left ventricular ecovery, especially in the initial 
reperfusion period, a sufficient leukocyte filtration rate 
would be essential during the terminal perfusion with 
blood cardioplegia. 
We conclude that leukocyte filtration with a single Pall 
BCIB filter for blood cardioplegia is merely effective up to 
800 ml of whole blood. When additional perfusions are 
necessary, a second filter is required to attempt effective 
leukocyte filtration. 
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